Ftse Mib
32.908,05
0,74%
DAX
18.068,21
0,26%
S&P 500
5.473,23
0,77%
NASDAQ
17.857,02
0,95%
Bitcoin
66.442,16
-0,30%
Registration Strip Icon for default Registrati gratuitamente per ottenere quotazioni in tempo reale, grafici interattivi, flusso di opzioni in tempo reale e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ SpringWorks Therapeutics Inc (SWTX) SpringWorks Therapeutics Inc (SWTX) Notizie

SpringWorks Therapeutics Inc

SWTX
36,67
-1,88 (-4,88%)
Dopo l'orario di negoziazione
Ultimo aggiornamento: 01:26:56
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
07/6/202422:15EDGAR2Form 8-K - Current report
05/6/202422:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/6/202413:00GLOBESpringWorks Therapeutics to Participate in the Goldman Sachs..
03/6/202422:37EDGAR2Form 144 - Report of proposed sale of securities
23/5/202423:13GLOBESpringWorks Therapeutics Announces Data to be Presented at..
17/5/202422:53EDGAR2Form 8-K - Current report
08/5/202413:00GLOBESpringWorks Therapeutics to Participate in the BofA..
02/5/202412:30GLOBESpringWorks Therapeutics Reports First Quarter 2024..
24/4/202419:31GLOBESpringWorks Therapeutics Announces Abstracts Accepted for..
18/4/202413:00GLOBESpringWorks Therapeutics to Report First Quarter 2024..
04/3/202412:30GLOBESpringWorks Therapeutics Initiates Rolling Submission of New..
01/3/202423:16EDGAR2Form 144 - Report of proposed sale of securities
29/2/202414:30GLOBESpringWorks Therapeutics Announces European Medicines Agency..
27/2/202414:28EDGAR2Form 8-K - Current report
27/2/202414:23EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
27/2/202413:29EDGAR2Form S-8 - Securities to be offered to employees in employee..
27/2/202412:51EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
27/2/202412:44EDGAR2Form 8-K - Current report
27/2/202412:30GLOBESpringWorks Therapeutics Reports Fourth Quarter and Full..
22/2/202413:00GLOBESpringWorks Therapeutics to Present at Upcoming Investor..
21/2/202400:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/2/202419:09EDGAR2Form 144 - Report of proposed sale of securities
14/2/202414:56EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
06/2/202403:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/2/202403:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/2/202422:38EDGAR2Form 144 - Report of proposed sale of securities
02/2/202422:01EDGAR2Form 8-K - Current report
31/1/202413:00GLOBESpringWorks Therapeutics to Participate in the Guggenheim..
09/1/202403:13EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202403:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202403:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202403:09EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202403:07EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202403:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/1/202412:30GLOBESpringWorks Therapeutics Highlights 2023 Accomplishments and..
21/12/202313:00GLOBESpringWorks Therapeutics to Present at the 42nd Annual J.P...
08/12/202322:05GLOBESpringWorks Therapeutics Announces Closing of Upsized Public..
06/12/202322:10EDGAR2Form 8-K - Current report
06/12/202322:05EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
05/12/202306:32GLOBESpringWorks Therapeutics Announces Pricing of Upsized Public..
04/12/202322:19EDGAR2Form 424B5 - Prospectus [Rule 424(b)(5)]
04/12/202322:13GLOBESpringWorks Therapeutics Announces Proposed Public Offering..
29/11/202313:00GLOBESpringWorks Therapeutics to Participate in the 6th Annual..
28/11/202315:00EDGAR2Form 8-K - Current report
28/11/202313:53DJNSpringWorks Shares Rise on FDA Approval for Tumor Treatment
28/11/202300:46DJNSpringWorks Gets FDA Approval for Desmoid Tumor Treatment
28/11/202300:04GLOBESpringWorks Therapeutics Announces FDA Approval of OGSIVEO™..
17/11/202313:00EDGAR2Form 8-K - Current report
16/11/202312:30GLOBESpringWorks Therapeutics Announces Positive Topline Results..
03/11/202302:02EDGAR2Form 144 - Report of proposed sale of securities
Apertura: 38,33 Min: 36,29 Max: 38,33
Chiusura: 38,55

La tua Cronologia

NASDAQ
SWTX
SpringWorks Therapeutics
USOTC
SPASY
SATS (PK)
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network